These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: Turkish adaptation of the short form of the Pelvic Organ Prolapse/Urinary Incontinence Sexual Function Questionnaire (PISQ-12): a validation and reliability study.
    Author: Bilgic Celik D, Beji NK, Yalcin O.
    Journal: Neurourol Urodyn; 2013 Nov; 32(8):1068-73. PubMed ID: 23359251.
    Abstract:
    AIM: The purpose of this methodological study is to evaluate the reliability and validity of a Turkish adaptation of the short form of the Pelvic Organ Prolapse/Urinary Incontinence Sexual Function Questionnaire (PISQ-12) used in assessing sexuality function in women with POP/UI. METHODS: The PISQ-12 was translated into Turkish; the adaptation of the PISQ-12 to Turkish language was performed via back-translation, the content validity of the questionnaire was conducted by experts in the field, test-retest reliability was examined with 40 women with UI and/or POP. PISQ-12 was administered to 120 women with pelvic floor dysfunction. The reliability and validity of the PISQ-12 were analyzed. Evaluation of the data was performed using Content Validity Index (CVI), Cronbach's alpha, test-retest reliability, item total correlation, and confirmatory factor analysis. RESULTS: CVI of the Turkish PISQ-12 was found 1.00 (% 100). Item-total correlations were between 0.42 and 0.68 (P < 0.001). The PISQ-12 had an adequate and high internal consistency (Cronbach's α = 0.74) as well as a high test-retest reliability (Pearson correlation coefficient, r = 0.961; P < 0.001). Factor analysis results revealed strong construct validity. CONCLUSION: The Turkish version of the PISQ-12 is a reliable, consistent and valid instrument to assess sexual function in women with urinary incontinence and/or pelvic organ prolapse. It is also a comprehensive and easily applicable instrument which as a treatment outcome or research tool in clinical practices.
    [Abstract] [Full Text] [Related] [New Search]